Immy Inc.

TROY, MI · Medtech · Private

rapid fungal diagnostic tests and assays

Claim this profile

Follows are private to you and power your alerts

Updated · immy.com

Sector
Medtech
Headquarters
TROY, MI
Latest Form D
$536K, Dec 2020
Total capital
$6.1M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$6.1M
21 Form D · last Dec 2020
70 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
4
4 pending · first 2015
Rank in peer group#31 of 160

Capital timeline

20112013201520172019FEDERAL ↑EQUITY ↓Cumulative $7.9M
20112013201520172019FEDERAL ↑EQUITY ↓Cumulative $7.9M

Latest events

  • Private capital raisedForm D · SEC · 21st filing$536K
  • Private capital raisedForm D · SEC · 20th filing$381K
  • Private capital raisedForm D · SEC · 19th filing$50K
  • Private capital raisedForm D · SEC · 18th filing$75K
  • Private capital raisedForm D · SEC · 17th filing$21K
  • Private capital raisedForm D · SEC · 16th filing$476K
  • Offering registeredForm D · SEC · 15th filing$1.8M
  • Private capital raisedForm D · SEC · 14th filing$25K
  • Private capital raisedForm D · SEC · 13th filing$39K
  • Private capital raisedForm D · SEC · 12th filing$277K
  • Private capital raisedForm D · SEC · 11th filing$63K
  • Private capital raisedForm D · SEC · 10th filing$550K
  • Private capital raisedForm D · SEC · 9th filing$350K
  • Private capital raisedForm D · SEC · 8th filing$70K
  • Private capital raisedForm D · SEC · 7th filing$400K
  • Private capital raisedForm D · SEC · 6th filing$250K
  • Private capital raisedForm D · SEC · 5th filing$790K
  • Private capital raisedForm D · SEC · 4th filing$294K
  • Private capital raisedForm D · SEC · 3rd filing$377K
  • Private capital raisedForm D · SEC · 2nd filing$252K
  • Private capital raisedForm D · SEC · 1st filing$812K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 160 peers

Line = median

Medtech · Instrument

  • Granted patents#31 · top 19%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings
  • Arinder G. MahalExecutive OfficerNamed in SEC Form D filings
  • Clarence G. ChandranDirectorNamed in SEC Form D filings
  • Clrence G. ChandranDirectorNamed in SEC Form D filings
  • David G. DandurandExecutive OfficerNamed in SEC Form D filings
  • Douglas Peter MagyariExecutive Officer, DirectorNamed in SEC Form D filings
  • John C. AdamsDirectorNamed in SEC Form D filings
Show all 14 people
  • John Arthur MarxerExecutive Officer, DirectorNamed in SEC Form D filings
  • Laureen Sue MagyariExecutive OfficerNamed in SEC Form D filings
  • Mark TytherleighExecutive Officer, DirectorNamed in SEC Form D filings
  • Mary Ann WehrExecutive OfficerNamed in SEC Form D filings
  • Robert G. LiggettExecutive Officer, DirectorNamed in SEC Form D filings
  • Robert G. Liggett, Jr.Executive Officer, DirectorNamed in SEC Form D filings
  • Salvatore Peter VilardiExecutive Officer, DirectorNamed in SEC Form D filings
  • Vyomesh G. JoshiDirectorNamed in SEC Form D filings

What it has protected

USPTO · 4 granted of 8
Show all 8 patent records
  • EMRI SYSTEMS LLPSimilar federal contract value in Medtech · null in contracts
  • BIOMERICA INCSimilar federal contract value in Medtech · null in contracts
  • BRUKER CORPSimilar federal contract value in Medtech · null in contracts
  • Minimally Invasive Spinal Technology, LLCSimilar federal contract value in Medtech · null in contracts
  • TriAgenics, IncSimilar federal contract value in Medtech · null in contracts
  • 3Spine, Inc.Similar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .